Literature DB >> 1909192

Elevated levels of circulating tumor necrosis factor-alpha, interferon-gamma, and interleukin-2 in systemic reactions induced by anti-CD4 therapy in patients with rheumatoid arthritis.

G Horneff, A Krause, F Emmrich, J R Kalden, G R Burmester.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1909192     DOI： 10.1016/1043-4666(91)90026-a

Source DB:  PubMed          Journal:  Cytokine        ISSN： 1043-4666            Impact factor:   3.861


× No keyword cloud information.
  5 in total

Review 1.  Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis.

Authors:  Jamie Campbell; David Lowe; Matthew A Sleeman
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

Review 2.  Anti-CD4 monoclonal antibodies in rheumatoid arthritis.

Authors:  E H Choy; G H Kingsley; G S Panayi
Journal:  Springer Semin Immunopathol       Date:  1998

Review 3.  Biological therapies directed against cells in autoimmune disease.

Authors:  Paul Hasler
Journal:  Springer Semin Immunopathol       Date:  2006-04-28

4.  Treatment of refractory juvenile chronic arthritis by monoclonal CD4 antibodies: a pilot study in two children.

Authors:  G Horneff; U Dirksen; H Schulze-Koops; F Emmrich; V Wahn
Journal:  Ann Rheum Dis       Date:  1995-10       Impact factor: 19.103

Review 5.  The Epitope-Specific Anti-human CD4 Antibody MAX.16H5 and Its Role in Immune Tolerance.

Authors:  Lilly Stahl; Anna Duenkel; Nadja Hilger; Uta Sandy Tretbar; Stephan Fricke
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.